A to Z of MS
Click on the relevant link for more information on a topic.
A to Z of MS CUPID
Cannabinoid Use in Progressive Inflammatory brain Disease
CUPID was a research trial looking at whether tetrahydrocannabinol (THC), one of the active ingredients in cannabis, could slow the increase of disability in people with progressive multiple sclerosis.
Initial results presented at the ABN meeting in May 2012 reported that THC was no better at reducing progression than placebo.
The trial, which began in 2006, involved 493 people at centres around the UK. Other outcome measures included whether THC provides symptomatic relief for spasticity. The trial also tried to assess the long-term safety of cannabis-based medicines.
The MS Trust funded the cost of MRI scans for this study.